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Sol–gel emulsionBioactive glass (BG) particles with nominal composition 60SiO2–36CaO–4P2O5 (mol%) were prepared by the
sol–gel emulsion method. The thermal parameters, morphology, and phase composition were characterized
by means of thermal analysis, scanning electron microscopy, X-ray diffraction, and FT-IR absorption spectros-
copy. The in vitro bioactivity of the samples was determined by immersing the samples in simulated body
ﬂuid. The ﬁndings indicated that the sol–gel emulsion method may be useful to prepare BG samples free of
crystallization.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Since 1969, bioactive glass (BG) ceramics prepared by melting with
different compositions and, consequently, distinct physico-chemical
features have been described in the literature [1]. The bioactivity of
these glasses derives from their ability to be converted into apatite,
which adhereswell to living bones. To obtain bioactive glasses prepared
by melting with reasonable adhesion to bones and negligible crystalli-
zation, a silica content below 60 (mol%) and high content of CaO, as
well as a Ca/P molar ratio between 1 and 5 are required. However, it is
a challenge to prepare glasses by melting in the CaO–P2O5 system
with a molar ratio CaO/P2O5 higher than 1.2, since melting tempera-
tures above 1500 °C are required [2]. Glasses and glass-ceramics with
molar ratio CaO/P2O5 in the 1.2–2.0 range have been obtained only by
using high contents of oxides such as SiO2, Na2O, MgO, TiO2, ZrO2, and
SrO [3–5]; nevertheless, crystalline phases have been precipitated in
the glass matrix, signiﬁcantly reducing the bioactivity. Addition of
CaF2 to the oxidematrix lowered the crystallization temperature, slight-
ly improved bioactivity [6], and provided a method for glass-ceramic
production under controlled crystallization [7].
Silicate glasses prepared by sol–gel show promise for use as bioma-
terials, since the sol–gel method is able to provide highly pure and
chemically homogeneous materials with a large surface area at low
temperature [8]. Hybrid materials incorporating functional organic
molecules can also be produced by sol–gel routes [9]. The reactivity of
the glasses depends on both their porosity and the number of
non-bridging oxygens (NBO) that can be controlled by the addition of
cations such as Na+, K+, and Mg2+ which induce a breakdown of the
glass network [10,11]. The sol–gel method also allows the preparationecnologia, Universidade Federal
0-900, Caixa Postal 549, Campo
n).
rights reserved.of bioactive glasses at low temperatures with SiO2 concentration up to
90 mol% [12,13].
The sol–gel process, despite being very promising to produce BG
samples, might lead to formation of unwanted glass-ceramic particles
even when stabilized at temperatures below the crystallization tem-
perature. This crystallization contributes to a reduction of the bioac-
tivity of the material [14,15].
It has been a challenging task to develop wet routes able to pro-
duce crystallization-free bioactive glasses. Here we demonstrate
that the sol–gel emulsion method can be used to synthesize BG sam-
ples with composition 60SiO2–36CaO–4P2O5 without crystallization.
The inﬂuence of the heat treatment on the structural properties and
phase composition of the bioactive glasses (BG) is also discussed.2. Experimental
Bioactive glass samples with nominal composition 60SiO2–
36CaO–4P2O5 (mol%) were prepared by the sol–gel emulsion method.
Distilled and deionized water, nitric acid HNO3 (QUIMEX, 65% BP),
tetraethyl orthosilicate TEOS (Sigma-Aldrich 98% PA), ethyl alcohol
(ISOF 95%), triethyl phosphate TEP (Sigma-Aldrich 99.8%) and calci-
um nitrate (Kinetic 99%) were used as precursors for the sol phase,
as described elsewhere [13].
The sol–gel emulsion approach is based on two phases: an oil
phase and an aqueous phase. The oil phase was formed from the sur-
factant Sorbitan Monooleate Span 80® (Fluka) diluted in ﬁltered ker-
osene, while the aqueous phase consisted of distilled and deionized
water as well as NH4·OH. The oil and aqueous phases were mixed
under high-energy ultrasound to produce an emulsion. The sol was
dripped under stirring and then centrifuged to separate the samples.
Next, the particles were dried in an oven at 100 °C for 24 h. After the
drying step, the sample was ground in an agate mortar and then
annealed at 600 °C for 4 h in a furnace under ambient atmosphere.
Fig. 1. (a) TG and (b) DSC curves of bioactive glass samples annealed at 600 °C.
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subsequently annealed at 750 °C for 2 h, hereafter termed E750.
The morphology was measured by scanning electron microscopy
(SEM) (JEOL 6830LV Microscope). Crystalline and amorphous phases
of the powders were determined by X-ray diffraction (XRD) using a
Rigaku apparatus (Rotaﬂex RU200B) with CuK radiation operating at
50 kV and 100 mA. The XRD patterns were analyzed using the JCPDS
data. Differential scanning calorimetry (DSC) and thermogravimetry
(TG) curves were obtained in a Shimadzu TA-50 thermogravimeter
using platinum crucibles and synthetic air. The vibrational groups in
the samples were identiﬁed by a Fourier transform infrared spectrosco-
py FT-IR spectrophotometer (Perkin-Elmer Spectrum 100) with an At-
tenuated Total Reﬂectance (ATR) accessory.
Bioactivity was evaluated in vitro by immersing the samples in
simulated body ﬂuid (SBF), as described by Kokubo et al. [18]. Pellets
of the particles were prepared and incubated at 37 °C for 4 and
10 days in about 50 mL of SBF. After each interval the samples were
washed using distilled water, dried at 50 °C for 24 h, and then stored
in a water-free container. Energy-dispersive X-ray spectroscopy
(EDS) measurements were performed to evaluate changes in the1600 1500 1400 1300 1200 1100 1000 900 800 700
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Fig. 2. FT-IR spectra of the E600 and E750 samples.relative contents of calcium and phosphorus in the samples submit-
ted to the SBF.3. Results and discussion
3.1. Thermal analysis
Fig. 1(a) shows the TG curve of the BG samples annealed at 600 °C.
The TG curve indicates a continuous and smooth mass loss up to
680 °C, which may be attributed to the release of adsorbed water. Al-
though decarbonation was observed in the 680–830 °C range, BG
samples synthesized using the emulsion method lost less mass in
this temperature range, indicating a low carbonate content in these
particles.
The endothermic event (Td) in the 680–830 °C range, shown in
the DSC curve in Fig. 1(b), indicates a non-oxidative decomposition
of carbonate residues, which is correlated to the mass loss observed
in the TG curve at the same temperature range. The E600 sample10 20 30 40 50 60 70 80
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Fig. 3. X-ray diffraction patterns of BG samples annealed at 600 and 750 °C.
Fig. 4. 50K magniﬁcation SEM micrographs of the E600 and E750 samples.
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peak temperatures of ﬁrst (Tc1) and second (Tc2) crystallizations at
890 and 1020 °C respectively.
Although the temperature of 600 °C has been used in several stud-
ies to stabilize the sol–gel samples, here the BG samples synthesized
by sol–gel emulsion were also annealed at 750 °C for 2 h. This
annealing temperature was chosen taking into consideration that
the release of impurities from the samples is almost complete at
this temperature. Furthermore, it is lower than Tg and Tc1 of the BG
samples, thus this annealing should prevent cluster formation,
sintering and thermally-activated crystallization of the samples.3.2. FT-IR measurements
Fig. 2 shows themid-infrared spectra of the BG samples stabilized at
600 and 750 °C. The bands centered at 1420, 1470, and 1520 cm−1 in
the E600 sample can be assigned to asymmetric stretching of (CO3)2−
groups, which are residual carbonates inherent to the sol–gel reac-
tion [8]. In contrast, the E750 sample did not exhibit these bands,
since the carbonates were removed during the stabilization procedure.
All infrared spectra displayed a broad band spanning between 850
and 1300 cm−1, which was composed of bands located at about 1230,
1070 and 1038 cm−1 assigned to the Si–O–Si stretching mode; and a
band centered at 935 cm−1 corresponding to the vibrational mode of
stretching of Si–O–NBO [8]. Absorption bands in the 900–970 and
1000–1100 cm−1 range have also been associated with stretching vi-
brations of PO43− groups, so that, despite the low concentration of phos-
phates in the glass matrix, their role is not ruled out [8].Fig. 5. 2K magniﬁcation SEM micrograp3.3. X-ray diffraction and microstructure measurements
Fig. 3 shows the XRD patterns of the E600 and E750 samples. The
XRD pattern of the E600 sample shows two broad halos centered at
about 22° and 31°, indicating not only that crystallization did not
occur, but also the existence of two amorphous phases. The halos ob-
served in the XRD pattern of the E600 sample are also observed in the
pattern of the E750 particles. However, the halo at about 31° in the
E750 sample, which appeared as a shoulder in the pattern of the
E600 sample, is predominant over the halo located at around 22°.
Therefore, the annealing temperature plays an important role in the
determination of the relative amount of the amorphous phases in
the samples synthesized by the emulsion method. Moreover, the
sample annealed at 750 °C showed an incipient crystallization of the
Ca5(PO4)2(SiO4)6 phase (JCPDS 83-1494).
The micrographs of the E600 and E750 samples shown in Fig. 4 re-
veal primary particles with diameters less than 100 nm, which are
agglomerated. The results also indicate that the sample annealed at
750 °C did not undergo sintering, preserving the same microstructur-
al characteristics of the E600 sample.
3.4. Bioactivity
Fig. 5 displays the SEM micrographs of the E600 and E750 pellet
samples as prepared and after 4 and 7 days immersed in simulated
body ﬂuid (SBF). The micrographs reveal the formation of spheres
over the entire surface of the pellets, as a result of the interaction be-
tween glass particles and the SBF. Enlarged images of the surfaces
show that spheres with similar diameters were formed (Fig. 6).hs of the E600 and E750 samples.
Fig. 6. 10K magniﬁcation SEM micrographs of the E600 and E750 samples.
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centrations of Ca and P present on the surfaces and spheres resulting
from the immersion time in SBF. The Ca/P ratios on the surfaces of
the E600 and E750 samples after 4 days of soaking were about 3.7
and 2.6, respectively. After 7 days of immersion, Ca/P ratios of ap-
proximately 3.3 and 2.2 were obtained for the E600 and E750 sam-
ples, respectively. On the other hand, the spheres formed on the
E600 and E750 pellets that were soaked for 4 days exhibited Ca/P ra-
tios of about 2.0 and 1.6, respectively, while the spheres observed on
the samples soaked in SBF for 7 days showed ratios of 1.6 and 1.4 for
the E600 and E750 samples, respectively. The ratios observed for the
spheres are similar to that expected for the stoichiometry of hy-
droxyapatite (~1.7), indicating the bioactive response of the
samples.
The mid-infrared spectra of the samples in the 800–1300 nm
range prior to and following SBF immersion, shown in Fig. 7, also cor-
roborate the bioactivity of the samples, due to the decrease of the Si–
NBO band located at around 935 cm−1. Several studies have shown800 900 1000 1100 1200 1300
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Fig. 7. FT-IR spectra of the E600 and E750 samples as prepared andthat the formation of hydroxyapatite is followed by the reduction of
this band [15–17].
4. Conclusions
The ﬁndings of this study indicated that the sol–gel emulsion meth-
od is appropriate to produce bioactive glasses without crystallization
and carbonate residue. In addition, the SEM micrographs indicated
that emulsion is a promising approach to synthesize particles with di-
ameters below 100 nm. The BG samples thermally stabilized at 600
and 750 °C exhibited different glassy structures, indicating that it is pos-
sible to manipulate the amorphous feature of the samples.
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